Skip to main content
. 2015 Jun 9;6(2):173–185. doi: 10.1007/s13300-015-0112-4

Fig. 4.

Fig. 4

Percentage of patients achieving glycemic control, weight reduction and control of cardiovascular risk factors after treatment with liraglutide. DBP diastolic blood pressure, HbA 1c glycated hemoglobin, SBP systolic blood pressure, WR weight reduction. *p < 0.001 for the comparison between baseline and after treatment (Chi-square test)